دورية أكاديمية
HPV related p16 INK4A and HSV in benign and potentially malignant oral mucosa pathologies.
| العنوان: | HPV related p16 INK4A and HSV in benign and potentially malignant oral mucosa pathologies. |
|---|---|
| المؤلفون: | Duś-Ilnicka I; Oral Pathology Department, Faculty of Dentistry, Wroclaw Medical University, Ul. Krakowska 26, Wroclaw, 50-425, Poland. irena.dus-ilnicka@umw.edu.pl., Hałoń A; Division of Clinical Pathology, Department of Clinical and Experimental Pathology, Wroclaw Medical University, Ul. Borowska 213, Wroclaw, Poland., Perra A; Section of Pathology, Department of Biomedical Sciences, University of Cagliari, Cittadella Universitaria - Monserrato, Monserrato, Italy., Radwan-Oczko M; Oral Pathology Department, Faculty of Dentistry, Wroclaw Medical University, Ul. Krakowska 26, Wroclaw, 50-425, Poland. |
| المصدر: | BMC oral health [BMC Oral Health] 2024 Mar 18; Vol. 24 (1), pp. 347. Date of Electronic Publication: 2024 Mar 18. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: BioMed Central Country of Publication: England NLM ID: 101088684 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6831 (Electronic) Linking ISSN: 14726831 NLM ISO Abbreviation: BMC Oral Health Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: London : BioMed Central, [2001- |
| مواضيع طبية MeSH: | Carcinoma, Squamous Cell*/pathology , Fibroma*/complications , Fibroma*/pathology , Mucocele*/complications , Mucocele*/pathology , Papillomavirus Infections*/complications, Female ; Humans ; Male ; Middle Aged ; Biomarkers, Tumor/analysis ; Cross-Sectional Studies ; Cyclin-Dependent Kinase Inhibitor p16/analysis ; Cyclin-Dependent Kinase Inhibitor p16/metabolism ; Human Papillomavirus Viruses ; Mouth Mucosa/pathology ; Adult ; Aged |
| مستخلص: | Background: The association of Human Papilloma Virus (HPV) and Human Syncytial Virus (HSV) infection with inflammatory and potentially malignant disorders of the oral cavity (OPMD) is unknown. The aim of this cross-sectional study was to stablish the expression of the p16 INK4A and HSV proteins, to test potential correlation between those parameters in biopsies from clinically diagnosed oral lesions. Methods: Immunochemical analysis of 211 formalin-fixed, paraffin-embedded (FFPE) blocks from 211 individuals was provided. The clinical diagnosis included in the research were Oral lichen planus (N = 30), Oral Leukoplakia (N = 13) Mucocele (N = 25), Erosion/ulceration/ inflammation of mucosa (N = 8), Overgrowth of mucosa (N = 135). Results: Two hundred eleven analyzed FFPE samples resulted with the median age of 58.5 years (the average age 54.0 years and SD ± 17 years). The female/male ratio was 2.3 (69.7% vs 30.3% respectively). All the samples positive for HSV also expressed p16 INK4A (p = 0.000), that's showed various levels of association with the diverse clinical diagnosis reaching the higher level in OM 49.1% (29 positive samples) and OLP 30.5% (18). p16 INK4A was associated with OLP at 30.5% (18), and fibroma 30.5%. HSV expression was mostly present in fibroma at 47.6% (10 positive samples). Conclusion: HSV and p16 INK4A positivity in relation to diagnosis of the biopsies showed statistically most often p16 INK4A in OLP and fibroma. The results of co-expression of p16 INK4A and HSV in mucocele and fibroma in oral mucosa suggest a cooperation between the molecular alterations induced by these two viruses. Squamous papilloma samples positive for p16 INK4A were also positive for HSV, suggesting that the putative pro-oncogenic action of HSV could be an early event. (© 2024. The Author(s).) |
| References: | Dent Med Probl. 2022 Oct-Dec;59(4):539-545. (PMID: 36478447) Open Virol J. 2012;6:249-56. (PMID: 23341860) J Virol. 2017 Oct 27;91(22):. (PMID: 28878080) Adv Biomed Res. 2015 Aug 31;4:173. (PMID: 26605212) J Clin Med. 2022 Sep 19;11(18):. (PMID: 36143134) Metabolites. 2022 Mar 26;12(4):. (PMID: 35448481) Gynecol Oncol Rep. 2021 Mar 30;36:100760. (PMID: 33869714) J Oral Pathol Med. 2008 Feb;37(2):107-21. (PMID: 18197856) PLoS One. 2019 Oct 3;14(10):e0223299. (PMID: 31581238) BMC Oral Health. 2017 Jun 29;17(1):103. (PMID: 28662707) Int J Clin Exp Pathol. 2019 Mar 01;12(3):1022-1028. (PMID: 31933914) Eur J Cancer B Oral Oncol. 1993 Jul;29B(3):215-9. (PMID: 8298425) BMC Oral Health. 2021 Jun 10;21(1):298. (PMID: 34112142) Clin Sci (Lond). 2017 Aug 10;131(17):2201-2221. (PMID: 28798073) Adv Clin Exp Med. 2019 Nov;28(11):1469-1476. (PMID: 30916899) World J Clin Cases. 2014 Dec 16;2(12):866-72. (PMID: 25516862) Exp Ther Med. 2018 May;15(5):4157-4166. (PMID: 29731815) J Investig Clin Dent. 2018 May;9(2):e12313. (PMID: 29322686) Pathology. 2020 Feb;52(2):179-191. (PMID: 31889547) Mol Diagn. 2003;7(2):73-83. (PMID: 14580227) J Obstet Gynaecol Res. 2017 Mar;43(3):429-435. (PMID: 28165175) Front Oncol. 2019 May 08;9:355. (PMID: 31134154) Virulence. 2015;6(3):244-8. (PMID: 25654476) Eur J Oral Sci. 2018 Oct;126 Suppl 1:49-66. (PMID: 30178562) Prev Med. 2011 Oct;53 Suppl 1:S5-S11. (PMID: 21962471) Anticancer Res. 2022 Jan;42(1):493-500. (PMID: 34969759) PLoS One. 2019 Jan 16;14(1):e0210070. (PMID: 30650110) Oral Oncol. 2018 Jul;82:91-99. (PMID: 29909908) BMJ Open. 2018 Aug 19;8(8):e022497. (PMID: 30122664) J Gen Virol. 2017 Apr;98(4):519-526. (PMID: 28150575) N Engl J Med. 2022 Nov 24;387(21):1999-2005. (PMID: 36378601) Pol J Pathol. 2020;71(2):138-145. (PMID: 32729304) Cancer Sci. 2013 Dec;104(12):1553-9. (PMID: 24344719) Aust Dent J. 2019 Mar;64(1):11-18. (PMID: 30238467) J Neurovirol. 2011 Dec;17(6):518-27. (PMID: 22139603) Oral Surg Oral Med Oral Pathol Oral Radiol. 2015 Jun;119(6):e306-14. (PMID: 25544404) Biomark Med. 2016 Sep;10(9):975-85. (PMID: 27586584) Br J Dermatol. 1999 Feb;140(2):343-6. (PMID: 10233235) Int J Cancer. 2005 Dec 10;117(5):831-6. (PMID: 15957167) Front Pharmacol. 2023 May 10;14:1182152. (PMID: 37234716) Pathol Res Pract. 2023 Aug;248:154656. (PMID: 37406376) Anticancer Res. 2012 Feb;32(2):571-80. (PMID: 22287747) J Oral Microbiol. 2019 Jun 25;11(1):1632129. (PMID: 31275530) J Clin Virol. 2012 Feb;53(2):116-20. (PMID: 22177275) J Invest Dermatol. 2015 Feb;135(2):418-424. (PMID: 25207820) Dent Med Probl. 2022 Oct-Dec;59(4):573-581. (PMID: 36583840) Virus Res. 2017 Mar 2;231:139-147. (PMID: 27826043) Pathologe. 1987 May;8(3):138-40. (PMID: 3303008) |
| فهرسة مساهمة: | Keywords: HPV; Herpesvirus 1; Human; Leukoplakia, Oral; Lichen Planus, Oral; Oncogenic viruses |
| المشرفين على المادة: | 0 (Biomarkers, Tumor) 0 (Cyclin-Dependent Kinase Inhibitor p16) |
| تواريخ الأحداث: | Date Created: 20240319 Date Completed: 20240320 Latest Revision: 20240321 |
| رمز التحديث: | 20240321 |
| مُعرف محوري في PubMed: | PMC10949823 |
| DOI: | 10.1186/s12903-024-04105-z |
| PMID: | 38500158 |
| قاعدة البيانات: | MEDLINE |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 1472-6831 |
|---|---|
| DOI: | 10.1186/s12903-024-04105-z |